RxDoctor Payments Data

Lindsay Romak, MD

Radiation Oncology · Newark, DENPI 1437479292

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,039 of the $2,738 with a category attached, or 74.5%. Siemens Medical Solutions USA, Inc. accounts for 89.7% of it on its own, with 3 other manufacturers making up the rest.

$2,738in general payments, 2019–2025

Across 15 payments — averaging $182.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$2K
  • Viewray Technologies Inc$153
  • Bioptics, Inc.$72
  • Angiodynamics, Inc.$59

What the payments were for

  • Travel & lodging$2,03974%
  • Food & beverage$69926%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Siemens Medical Solutions USA, Inc.12$2,455
Viewray Technologies Inc1$153
Bioptics, Inc.1$72
Angiodynamics, Inc.1$59

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few radiation oncology providers in Delawareto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$351,295
Medicare patients
346
Services billed
3,261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mometasone Furoate79$1,500

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →